Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2017-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.biopha.2017.02.010PMID 28222401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats

  2016cited by this paper
• Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice

  2016cited by this paper
• Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats

  2015cited by this paper
• DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats

  2015cited by this paper
• Effect of Metformin and Sitagliptin on Doxorubicin-Induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation, and Apoptosis

  2015cited by this paper
• Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage

  2015cited by this paper
• DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus

  2014cited by this paper
• 'Ashvagandharishta' prepared using yeast consortium from Woodfordia fruticosa flowers exhibit hepatoprotective effect on CCl4 induced liver damage in Wistar rats.

  2014cited by this paper
• Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

  2014cited by this paper
• TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells.

  2013cited by this paper
• Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney

  2013cited by this paper
• Biology and significance of the JAK/STAT signalling pathways

  2012cited by this paper
• Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis.

  2012cited by this paper
• Evaluation of the hepatoprotective effect of green tea extract and selenium on CCL4-induced fibrosis

  2012cited by this paper
• Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis.

  2012cited by this paper
• Silymarin in the prevention and treatment of liver diseases and primary liver cancer.

  2012cited by this paper
• Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis

  2012cited by this paper
• Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward.

  2011cited by this paper
• Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.

  2011cited by this paper
• Protective effect of Panax ginseng against serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl4).

  2011cited by this paper
• Effects of standardized bilberry fruit extract (Mirtoselect®) on resolution of CCl4-induced liver fibrosis in mice.

  2011cited by this paper
• Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus.

  2011cited by this paper
• Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats.

  2011cited by this paper
• Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.

  2011cited by this paper
• Pathogenesis of liver fibrosis.

  2011cited by this paper
• The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats.

  2011cited by this paper
• Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's - derived fibroblasts

  2011cited by this paper
• Antifibrotic Therapies: Will We Ever Get There?

  2010cited by this paper
• Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)

  2010cited by this paper
• DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes.

  2010cited by this paper
• The incretin system and its role in type 2 diabetes mellitus.

  2009cited by this paper
• Molecular pathogenesis of liver fibrosis.

  2009cited by this paper
• Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.

  2009cited by this paper
• (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.

  2009cited by this paper
• A novel model of CCl4-induced cirrhosis with ascites in the mouse.

  2009cited by this paper
• Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.

  2008cited by this paper
• Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads

  2008cited by this paper
• Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats.

  2008cited by this paper
• Appearance of α‐smooth‐muscle‐actin‐positive cells in hepatic fibrosis

  2008cited by this paper
• Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats

  2008cited by this paper
• Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes.

  2007cited by this paper
• Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.

  2007cited by this paper
• Dipeptidyl Peptidase-4 Inhibitors

  2007cited by this paper
• Emerging insights into Transforming growth factor β Smad signal in hepatic fibrogenesis

  2007cited by this paper
• Hepatic stellate cells and the reversal of fibrosis

  2006cited by this paper
• Structure and function in dipeptidyl peptidase IV and related proteins.

  2006cited by this paper
• Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX‐2 human stellate cell line

  2005cited by this paper
• Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability

  2005cited by this paper
• Antifibrotic effects of a tissue inhibitor of metalloproteinase‐1 antibody on established liver fibrosis in rats

  2004cited by this paper
• Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model

  2003cited by this paper
• Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

  2003cited by this paper
• Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.

  2003cited by this paper
• Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell.

  2003cited by this paper
• Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum).

  2003cited by this paper
• Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection.

  2002cited by this paper
• Chemokines in liver inflammation and fibrosis.

  2002cited by this paper
• The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.

  2002cited by this paper
• Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C.

  2001cited by this paper
• Gamma Glutamyl Transferase

  2001cited by this paper
• Mechanism of Carbon Tetrachloride-Induced Hepatotoxicity. Hepatocellular Damage by Reactive Carbon Tetrachloride Metabolites

  2001cited by this paper
• A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite.

  2001cited by this paper
• Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis

  2000cited by this paper
• Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis

  1999cited by this paper
• Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride‐treated IL‐6‐deficient mice

  1999cited by this paper
• Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts.

  1997cited by this paper
• Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma.

  1997cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface.

  1992cited by this paper
• Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis.

  1991cited by this paper
• Experimental Models of Hepatic Fibrosis: A Review

  1990cited by this paper
• PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN

  1989cited by this paper
• Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix.

  1989cited by this paper
• A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues.

  1981cited by this paper
• Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood.

  1979cited by this paper
• Effect of silybin on the hepatic microsomal drug-metabolising enzyme system in the rat.

  1974cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• Sitagliptin alleviates cyclophosphamide-induced oxidative stress and testicular toxicity in Wistar rats

  2026cites this paper
• HPLC-HRMS/MS and anti-inflammatory effects of bunya pine resin through multifaceted pathway modulation: NUMB/NOTCH1/HES1/mTOR/ PI3K/HMGB1 signaling cascades.

  2025cites this paper
• Activating Hepatic Progenitor Stem Cells to Regenerate Liver Cells After Liver Damage Induced by CCl4 Using Targeting Silymarin-Loaded Albumin/Hyaluronic Acid Nanoparticles.

  2025cites this paper
• Advancing fatty liver research in dairy cows: Development of a bovine liver organoid model.

  2025cites this paper
• Evaluating the role of targeted silymarin loaded hyaluronic acid/protein nanoparticles in activating hepatic progenitor stem cells for liver regeneration after CCl4-induced liver damage.

  2025cites this paper
• Study of reparative processes and immune mechanisms in liver tissues and blood plasma of rats against the background of loading with plant extracts and induced oxidative stress

  2024cites this paper
• Berberine-Loaded PVCL-PVA-PEG Self-Assembled Micelles for the Treatment of Liver Fibrosis

  2024cites this paper
• A First Metabolite Analysis of Norfolk Island Pine Resin and Its Hepatoprotective Potential to Alleviate Methotrexate (MTX)-Induced Hepatic Injury

  2024cites this paper
• Silymarin and Inflammation: Food for Thoughts

  2024cites this paper
• Protective Effects of Phytic Acid on CCl4-Induced Liver Fibrosis in Mice

  2023cites this paper
• A comparative study on the hepatoprotective effect of selenium-nanoparticles and dates flesh extract on carbon tetrachloride induced liver damage in albino rats

  2023cites this paper
• Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer

  2023cites this paper
• Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review

  2022cites this paper
• Silymarin Protects against Acute Liver Injury Induced by Acetaminophen by Downregulating the Expression and Activity of the CYP2E1 Enzyme

  2022cites this paper
• Gemigliptin Alleviates Succinate Induced Endoplasmic Reticulum Stress and Activation of Hepatic Stellate Cells

  2022cites this paper
• Physiological and Immunological Study for the Effects of Onopordum Acanthium L. Seeds Oil in Male Rats Treated with CCL4

  2022cites this paper
• Mechanistic Insights into the Pharmacological Significance of Silymarin

  2022cites this paper
• Effect of 4-hydroxychalcone as preventive and curative treatment in Wistar rats with liver injury.

  2022cites this paper
• Huangjia Ruangan Granule Inhibits Inflammation in a Rat Model with Liver Fibrosis by Regulating TNF/MAPK and NF-κB Signaling Pathways

  2022cites this paper
• Mechanisms underlying the hepatoprotective effect of silymarin on fluoxetine-induced liver injury in rats: the implication of peroxisome proliferator–activated receptor-gamma (PPAR-γ)

  2022cites this paper
• Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?

  2022cites this paper
• Evaluation of hepatoprotective effect of Nebivolol and sodium copper Chlorophyllin on CCL4-induced hepatotoxicity in mice.

  2022cites this paper
• Metformin versus Silymarin as Hepatoprotective Agents in Mice Fibrotic Model Caused by Carbon Tetrachloride.

  2022cites this paper
• Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats

  2021cites this paper
• Silymarin mitigates bile duct obstruction-induced cholemic nephropathy

  2021cites this paper
• Synergistic effects of sitagliptin and losartan against fipronil-induced hepatotoxicity in rats

  2021cites this paper
• Preventive effect of novel nanomicelle of silymarin on liver injury induced by carbon tetrachloride in rat

  2021cites this paper
• Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation/NF-κB inhibition.

  2021cites this paper
• Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug.

  2021cites this paper
• 'Silymarin' a Potential Treatment Targeting Hepatic Fibrosis of Schistosomiasis

  2021cites this paper
• Hepatoprotective and Antioxidant Activities of Combination of Cinnamomum zeylanicum and Zingiber officinale in CCl4-intoxicated Rats

  2020cites this paper
• Beneficial and deleterious effects of sitagliptin on a methionine/choline-deficient diet-induced steatohepatitis in rats.

  2020cites this paper
• Ganoderma lucidum attenuates and prevents CCl4-induced hepatic and renal damage in Sprague – Dawley Rats -

  2020cites this paper
• Hepatoprotective Impact of Geraniol Against CCl4-Induced Liver Fibrosis in Rats.

  2020cites this paper
• A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds.

  2020cites this paper
• The Effect of Humulus lupulus Extract on Serum Biochemical Parameters in Carbon Tetrachloride-induced Hepatotoxicity in Rats

  2020cites this paper
• Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling.

  2020cites this paper
• Derivatization-based magnetic dummy molecularly imprinted polymers integrated with 4-plex stable isotope labeling derivatization strategy for specific and rapid determination of L-hydroxyproline in human serum.

  2020cites this paper
• Effects and Safety of Sitagliptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

  2020cites this paper
• The hepatoprotective effect of sitagliptin against hepatic ischemia reperfusion-induced injury in rats involves Nrf-2/HO-1 pathway

  2019cites this paper
• NATURALLY DERIVED COMPOUNDS USED FOR PREVENTION OR REGRESSION OF EXPERIMENTALLY INDUCED LIVER FIBROSIS

  2019influential citation
• Investigation of the positive effects of silymarin on valproic acid-induced liver damage in rats

  2019cites this paper
• Anti-fibrotic activity of natural products, herbal extracts and nutritional components for prevention of liver fibrosis: review

  2019cites this paper
• Silimarinin, ratlarda valproik asitin indüklediği karaciğer hasarı üzerine olumlu etkilerinin araştırılması

  2019cites this paper
• In vivo protective effect of Rosmarinus officinalis oil against carbon tetrachloride (CCl4)-induced hepatotoxicity in rats

  2019influential citation
• Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice.

  2019cites this paper
• Efficiency of Sophora flavescens-Fructus Ligustri Lucidi Drug Pairs in the Treatment of Liver Fibrosis Based on the Response Surface Method

  2019cites this paper
• Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell.

  2019cites this paper
• The protective effect of Zataria multiflora Boiss essential oil on CCl4 induced liver fibrosis in rats

  2019cites this paper
• Ginger potentiates the effects of silymarin on liver fibrosis induced by CCL4: the role of galectin-8.

  2019cites this paper
• Potential Protective Role of Sitagliptin (Januvia) Against Acetaminophen-Induced Hepatotoxicity in Adult Albino Rats

  2019influential citation
• Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases

  2018cites this paper
• Food components with antifibrotic activity and implications in prevention of liver disease.

  2018cites this paper
• Alpha lipoic acid exerts antioxidant effect via Nrf2/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats.

  2018cites this paper
• Investigation of the hepatoprotective effect of Corydalis saxicola Bunting on carbon tetrachloride‐induced liver fibrosis in rats by 1H‐NMR‐based metabonomics and network pharmacology approaches

  2018cites this paper
• Atriplex halimus aqueous extract abrogates carbon tetrachloride-induced hepatotoxicity by modulating biochemical and histological changes in rats

  2018cites this paper
• Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights from iTRAQ-Based Quantitative Proteomics

  2017cites this paper
• Inhibitory effect of silymarin on CCl4-induced liver fibrosis by reducing Ly6Chi monocytes infiltration.

  2017influential citation
• Comparative Evaluation of Hepatoprotective Activity of Xymedon Preparation Derivatives with Ascorbic Acid and Methionine

  2017cites this paper